COCRYSTAL PHARMA INC (COCP)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Sam Lee |
| Employees: | 10 |
| Web site: | cocrystalpharma.com |
|
19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
(786) 459-1831
| |
| Date | Ratio |
|---|---|
| 2018-01-24 | 1:30 |
| 2022-10-11 | 1:12 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Cocrystal Pharma, Inc. focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection.
Please log in first to see chart